Elite Pharmaceuticals, Inc. (ELTP) Reports Q1 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts ELTP Hot Sheet
Join SI Premium – FREE
Elite Pharmaceuticals, Inc. (OTC: ELTP) reported Q1 results. Revenue for the quarter came in at $9 million.
For earnings history and earnings-related data on Elite Pharmaceuticals, Inc. (ELTP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Misses Q3 EPS by 20c, Beats on Revenue; Cuts FY EPS Guidance
- Berenberg Downgrades Rheinmetall AG (RHM:GR) (RNMBY) to Hold
- Citi cuts Viper Energy price target to $52 ahead of Q3 earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
